945217-56-1 Usage
Uses
Used in Medicinal Chemistry:
3-Methyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole is utilized as a key component in the development of pharmaceuticals, targeting a variety of biological processes. Its structural characteristics make it a versatile molecule for creating new drugs with potential therapeutic applications.
Used in Drug Discovery:
In the field of drug discovery, 3-Methyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole is employed as a starting material for the synthesis of novel compounds with potential medicinal properties. Its derivatives are being explored for their therapeutic potential, particularly in the treatment of various diseases, highlighting its importance in advancing pharmaceutical research.
Used in the Synthesis of Bioactive Compounds:
3-Methyl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole serves as a valuable building block in the synthesis of diverse classes of bioactive compounds. Its incorporation into these compounds can lead to the development of new drugs with improved efficacy and safety profiles, contributing to the ongoing efforts in medicinal chemistry to create more effective treatments for a range of health conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 945217-56-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,5,2,1 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 945217-56:
(8*9)+(7*4)+(6*5)+(5*2)+(4*1)+(3*7)+(2*5)+(1*6)=181
181 % 10 = 1
So 945217-56-1 is a valid CAS Registry Number.
InChI:InChI=1S/C6H9N3/c1-4-5-2-7-3-6(5)9-8-4/h7H,2-3H2,1H3,(H,8,9)
945217-56-1Relevant articles and documents
AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 36, (2008/06/13)
The present invention is directed to novel substituted aminocyclohexanes of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
-
Page/Page column 18, (2008/06/13)
The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
